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1. Introduction 
Thyroid receptors for thyrotrophin (TSH) and 
thyroid-stimulating antibodies (TSAb) are closely 
related as indicated by the ability of TSAb to inhibit 
the binding of labelled TSH to thyroid membranes 
[l-4] and to isolated thyroid cells [S ,6] . The effect 
of TSAb on the TSH-TSH receptor interaction may 
be due to direct binding of the antibody to the TSH 
receptor. Alternatively, TSAb may bind to a site 
different from the TSH receptor in such a way as to 
induce changes in the thyroid membrane and cause 
inactivation of the TSH receptor. In order to investigate 
these two possibilities we have studied the interaction 
between TSAb and solubilised human TSH receptors. 
Our data indicate that TSAb inhibits the binding of 
labelled TSH to soluble TSH receptors and provide 
evidence for the concept that TSAb is an antibody to 
the TSH receptor. 
2. Methods 
A crude membrane fraction was prepared from 
human thyroid tissue (obtained at partial thyroid- 
ectomy for Graves’ disease) as described [2,3]. All 
manipulations were performed at 0-4°C unless other- 
wise indicated. The membranes were suspended in 
50 mM NaCl; 10 mM Tris-HCl, pH 7.4 (Tris/NaCl) 
containing 0.1% Triton X-100 (2 ml Triton buffer/g 
equiv. thyroid membranes) and centrifuged at 
100 000 X g for 1 h. The supernatant, which con- 
tained only small amounts of soluble TSH receptors, 
was discarded and the sediment resuspended in Tris/ 
NaCl containing 0.5% Triton (1.5 ml Triton buffer/g 
equiv. thyroid membranes) and resedimented by 
centrifugation at 100 000 X g for 1 h. The supernatant 
which contained considerable TSH receptor activity 
and about 100 pg/ml protein [7] was used immediately 
or stored at -70°C. The TSH-binding properties of 
the Triton extracts were studied using bovine TSH 
(30 units/mg, a generous gift from Dr J. G. Pierce) 
labelled with “‘1 [2,3,8] . Bound and free labelled 
TSH were separated by chromatography on a 
2.6 X 40 cm column of Sepharose 6B in Tris/NaCl, 
containing 0.05% Triton, or by precipitation with 
polyethylene glycol (PEG) mol. wt 4000. 
Maximum labelled-TSH binding to soluble receptors 
occurred after an overnight incubation at 0°C. In a 
typical experiment 50 ~1 soluble receptor (5 pg pro- 
tein) were added to 100 fi test material (immuno- 
globulin or hormone) in Tris/NaCl containing 1 mg/ml 
bovine serum albumin (Tris/NaCl/BSA). Labelled TSH 
(5000-10 000 cpm in 50 ~1 Tris/NaCl/BSA, containing 
0.5% Triton) was then added. In addition, reaction 
mixtures which contained test material and labelled 
TSH, but with 50 d Triton-albumin buffer instead 
of soluble receptor, were included. After 18-24 h at 
O”C, 1.5 mg normal human IgG in 500 ~1 Tris/NaCl 
was added, followed immediately by 700 ~130% PEG 
in 1 M NaCl. The labelled TSH-TSH receptor complex, 
precipitated together with carrier IgG, was sedimented 
by centrifugation (20 000 X g for 15 min) and counted 
for 12’I. In the absence of soluble receptor, 8-12% of 
the labelled TSH was associated with the PEG precipi- 
tate and this was not affected by the addition of up to 
3 pg (0.1 units) unlabelled TSH (1 unit/mg, gift from 
Armour Pharmaceuticals). In the presence of’soluble 
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receptor, 30-40% of the labelled TSH was precipitated 
with PEG and this was reduced to 9-12% by addition 
of 3 pg unlabelled hormone. Results were expressed 
as the difference between the amount of labelled TSH 
precipitated in the presence and absence of soluble 
TSH receptor, except for Scatchard analysis [9]. In 
this case non-specific binding was taken as the amount 
of labelled hormone bound in the presence of 3 /*g 
unlabelled TSH. 
Immunoglobulin G was prepared from Graves’ and 
normal human sera by precipitation with ammonium 
sulphate followed by chromatography on Sephadex 
G-200 [lo] . The IgG preparations were monitored 
for their ability to inhibit the binding of labelled TSH 
to human thyroid membranes by the method [3]. 
The binding of labelled TSH to thyroid membranes 
was also studied by this method except that the incu- 
bation of hormone and membranes was carried out at 
0°C and IgG and PEG were added prior to separation 
of bound and free, as described above for the studies 
with soluble receptors. The thyroid-stimulating activity 
of the IgGs was studied by the method [ 1 l] adapted 
for use with human thyroid cells. 
Human chorionic gonadotrophin (hCG) (gift from 
National Pituitary Agency) was labelled with “‘1 under 
the conditions used to label TSH and run on Sephadex 
G-100 (40 X 2.6 cm column in Tris/NaCl) to remove 
aggregates and free “‘1 The labelled hormone showed . 
similar testicular-binding properties to those described 
[121. 
3. Results 
Chromatography of mixtures of labelled TSH and 
0.5% Triton extracts of human thyroid membranes 
Fig.1. Chromatography of mixtures of labelled bovine TSH 
(100 000 cpm in 0.5 ml), IgG (0.5 ml) and 0.5% Triton 
extracts of human thyroid membranes (1 ml) on Sepharose 
6B. (a) 100 pg normal human IgG; (b) 100 pg TSAb-IgG; 
(c) 4 mg TSAb-IgC. Reaction mixtures without IgG or 
containing 4 mg normal human IgG gave the same elution 
profile as that shown in (a). Reaction mixtures containing 
3 c(g unlabelled bovine TSH instead of TSAb gave the same 
elution profile as that shown in (c). The elution volumes of 
blue dextran 2000, IgM, IgA dimer, IgG, haemoglobin, TSH 
monomer and Na’*‘I are shown as A, B, C, D, E, F and G, 
respectively. Column dimensions 2.6 X 40 cm; buffer Tris/ 
NaCl containing 0.05% Triton; flow rate 20 ml/h. 
on Sepharose 6B resolved the mixtures into two 
principal peaks of radioactivity (fig.1). Calibration 
of the column with different proteins (fig.1) indicated 
that the two peaks were characteristic of labelled 
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TSH monomer (mol. wt 3 X 104) and a substance significant effect. Similarly, no interaction between 
corresponding to approx. mol. wt 3 X 10’. The for- labelled TSH and Triton extracts of human testis could 
mation of the high molecular weight peak was inhibited be demonstrated using the PEG method. Studies with 
in a dose-dependant manner by unlabelled bovine TSH. the PEG method indicated that soluble TSH receptor 
When the high molecular weight peak was isolated, activity was heat labile. Inactivation was complete after 
mixed with 3 pg unlabelled bovine TSH and rerun on heating for 1 h at 56°C and the preparations showed 
the Sepharose column, 95% of the radioactivity eluted only a small proportion of their initial TSH-binding 
as TSH monomer. Using Sepharose, no interaction activity after 1 h at 37’C or 18 h at 2O’C. This was in 
could be demonstrated between 1251-labelled hCG and contrast to membrane-bound TSH receptors which 
soluble TSH receptors. were stable for several hours at 37°C. The soluble 
Furthermore, there was no interaction between receptors were stable for several days at 4°C and for 
1251-labelled TSH and 0.5% Triton extracts of mem- several weeks at -70°C. 
branes prepared from a human testis (obtained at Labelled TSH binding to soluble and membrane- 
autopsy a few hours after death). Data obtained with bound receptors showed similar kinetics at 0°C and 
the Sepharose method of separating bound and free maximal binding to both preparations occurred 
TSH were in good agreement with those obtained with between 6 h and 18 h. Satisfactory binding data were 
the PEG method. Results of studies using the PEG not obtained with soluble receptor preparations at 
method are shown in fig.2. Labelled-TSH binding was 37°C presumably because the soluble receptors were 
inhibited in a dose-dependant manner by unlabelled rapidly inactivated at this temperature. Scatchard 
TSH whereas hCG, insulin, and ACTH showed no analysis [9 ] of the TSH-soluble TSH-receptor inter- 
action gave curved plots similar to those observed for 
the TSH-membrane-bound TSH-receptor interaction 
1.2 
B 
r 
(fig.3). Comparison of binding data obtained from 
EG several different thyroid glands suggested that 0.5%. 
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Fig.2. The effects of u&belled TSH (o), insulin (o), ACTH I I 11 11 11 11 II 1 I 
(A) and hCG (0) on the binding of labelled TSH to soluble 0 0.5 10 
TSH receptors. Bound and free labelled TSH were separated 
by PEG precipitation. Binding data were expressed as: 
TSH bound (ng) 
Fig.3. Scatchard analysis [9] of labelled TSH-binding to 
B % labelled TSH bound in the presence of unlabelled hormone 
-= 15 mg equiv. human thyroid membranes (A) and to 50 ~1 
BO 
% labelled TSH bound in the absence of unlabelled hormone soluble TSH receptors (0). 
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Fig.4. The effect of TSAb from 3 different patients on the 
labelled TSH-binding to soluble TSH receptors. Bound and 
free labelled TSH were separated by PEG precipitation and 
results expressed as: 
B o/o labelled TSH bound in the presence of TSAb 
-= __- 
BO 
% labelled TSH bound in the presence of normal IgG 
TSAb was diluted in normal human IgG so that the total 
IgG concentration in each reaction mixture was the same. 
Triton extracts of human thyroid membranes con- 
tained of the order of 20-50% original membrane- 
TSH binding activity. 
Immunoglobulin G with thyroid-stimulating anti- 
body activity inhibited the interaction between 
labelled TSH and soluble TSH receptors in a dose- 
dependant manner as judged by chromatography on 
Sepharose 6B (fig.1) or PEG precipitation (fig.4). 
Analysis by gel filtration or PEG precipitation of 
mixtures which contained TSAb and labelled TSH 
only, showed that no direct interaction between the 
IgG and labelled TSH occurred. 
4. Discussion 
The studies with ‘251-labelled TSH and 0.5% Triton 
extracts of human thyroid membranes indicated that 
the Triton extracts contained a heat labile substance 
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which interacted specifically and reversibly with TSH 
to form a complex which appeared to have approx. 
mol. wt 3 X 10’. However chromatography of a solu- 
tion containing 0.5% Triton (in Tris/NaCl) only on 
Sepharose 6B in 0.05% Triton (in Tris/NaCl) and 
monitoring the column eluant by extinction at 
280 nm indicated that the Triton solution itself con- 
tained three principal components with mol. wts IO’, 
2 X 10’ and 3 X 106. These components were pre- 
sumably different sized Triton micelles [ 131 and when 
Triton was used to extract human thyroid membranes, 
hydrophobic membrane components, including the 
TSH receptor, were probably incorporated into the 
micelles. Consequently, the Triton micelles would be 
expected to make a considerable contribution to the 
app. mol. wt 3 X 10’ observed for the TSH-TSH 
receptor complex. 
These observations can be compared with [I] 
where Triton extracts of guinea-pig thyroid mem- 
branes/labelled TSH mixtures were found to contain 
2 species of soluble, labelled-hormone-receptor com- 
plex with mol. wts 5 X 10’ and 1.5 X IO’. Lithium 
diiodo-salicylate extracts of bovine thyroid membranes 
contain TSH-receptor activity with mol. wts ranging 
from 1.5 X lo4 - 2.8 X 10’ [14]. Furthermore, 
treatment of this mixture with trypsin converted the 
high molecular weight components to a component 
with mol. wt 1.5 X IO4 - 3 X 104. The apparent 
differences between the soluble TSH-receptor activi- 
ties described in these and our own studies probably 
reflected species differences and differences in the 
conditions used to extract and analyse the receptors. 
The binding of labelled TSH to soluble receptor 
preparations was inhibited in a dose-dependant 
manner by TSAb (figs.l,4). Gel filtration and PEG 
precipitation studies indicated that no direct inter- 
action between TSAb and labelled TSH occurred (i.e., 
TSAb did not show any TSH-binding activity). Also, 
mixtures of TSAb, soluble TSH receptor and labelled 
TSH did not contain any material with a molecular 
weight characteristic of a trimolecular complex, con- 
sisting of TSAb, soluble TSH receptor and labelled 
TSH (fig.1). A similar study [l] was unable to demon- 
strate a trimolecular complex of TSAb, soluble TSH 
receptor and labelled TSH in Triton extracts of mix- 
tures of TSAb, guinea pig thyroid membranes and 
labelled TSH. 
These observations suggest hat TSAb binds directly 
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to the human TSH receptor and provide evidence for 
the concept that thyroid-stimulating antibodies are 
TSH receptor antibodies. 
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